JAMA Network
About The Study: This study found an association between glucagonlike peptide-1 receptor agonist (GLP-1RA) use and a lower risk of acute asthma exacerbations in adolescents with overweight or obesity. The findings suggest a potential dual benefit for this population, where a single class of medication could address both weight management and lower risk for asthma exacerbation, thereby potentially reducing the burden of 2 common and interconnected chronic conditions.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
